Adoption of a biomarker in clinical practice: from bench to bedside

被引:2
|
作者
Dehoux, Monique [1 ]
Chenevier-Gobeaux, Camille [2 ]
Ray, Patrick [3 ]
Claessens, Yann-Erick [4 ]
Lefevre, Guillaume [5 ]
机构
[1] Hop Bichat Claude Bernard, AP HP, Biochim Lab, F-75877 Paris 18, France
[2] AP HP, GH Cochin Broca Hotel Dieu, Biochim Lab, Paris, France
[3] Univ Paris 06, Hop Tenon, AP HP, Serv Accueil Urgences, Paris 6, France
[4] Ctr Hosp Princesse Grace, Dept Med Urgence, Monaco, Monaco
[5] Hop Tenon, AP HP, Lab Biochim & Hormonol, F-75970 Paris, France
关键词
biomarkers; evaluation; quality; BIOLOGICAL VARIATION; NATRIURETIC PEPTIDE; TROPONIN; STANDARDIZATION; PERFORMANCE; VALIDATION; COPEPTIN; QUALITY; MARKERS; ASSAYS;
D O I
10.1684/abc.2012.0779
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Although numerous diagnostic and/or prognostic biomarkers are proposed in the literature, only a limited number of them are finally used in daily practice. The necessary steps to prove their clinical interest include: 1) an exhaustive clinical and statistical evaluation demonstrating not only the added value of the marker with regard to the existing validated tools but also the modification of the clinical practice induced by the knowledge of the result of the biomarker; 2) an evaluation of the pre-analytical, and analytical performances of its measure necessary to the reliability of the results; 3) an evaluation of its biological variation. These steps are a major prerequisite to an effective, reliable and optimal clinical interpretation of the biomarker, and should be validated for each routine biomarker.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 50 条
  • [1] From bench to MS bedside: Challenges translating biomarker discovery to clinical practice
    Rajasekharan, Sathyanath
    Bar-Or, Amit
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 248 (1-2) : 66 - 72
  • [2] From Bench to Every Bedside: Improving the Adoption of Evidence-Based Practices
    Rodwin, Benjamin A.
    Merchant, Naseema B.
    SOUTHERN MEDICAL JOURNAL, 2020, 113 (11) : 538 - 540
  • [3] ST2 as a Cardiovascular Risk Biomarker: From the Bench to the Bedside
    Januzzi, James L., Jr.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2013, 6 (04) : 493 - 500
  • [4] Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside
    Patel, Shivangi
    Sharma, Dilip
    Uniyal, Ankit
    Akhilesh
    Gadepalli, Anagha
    Tiwari, Vinod
    METABOLIC BRAIN DISEASE, 2022, 37 (07) : 2197 - 2211
  • [5] Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside
    Shivangi Patel
    Dilip Sharma
    Ankit Uniyal
    Anagha Akhilesh
    Vinod Gadepalli
    Metabolic Brain Disease, 2022, 37 : 2197 - 2211
  • [6] From bench to bedside: translational insights into aging research
    Pandey, Kanti Bhooshan
    FRONTIERS IN AGING, 2025, 6
  • [7] Applications of western blot technique: From bench to bedside
    Meftahi, Gholam Hossein
    Bahari, Zahra
    Mahmoudabadi, Ali Zarei
    Iman, Maryam
    Jangravi, Zohreh
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2021, 49 (04) : 509 - 517
  • [8] Bisphosphonates and Osteonecrosis of the Jaw: Moving from the Bedside to the Bench
    Allen, Matthew R.
    CELLS TISSUES ORGANS, 2009, 189 (1-4) : 289 - 294
  • [9] CDG Therapies: From Bench to Bedside
    Brasil, Sandra
    Pascoal, Carlota
    Francisco, Rita
    Marques-da-Silva, Dorinda
    Andreotti, Giuseppina
    Videira, Paula A.
    Morava, Eva
    Jaeken, Jaak
    Ferreira, Vanessa dos Reis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [10] Extracellular vesicles: from bench to bedside
    Yang Chen
    Li Yu
    Current Medicine, 1 (1):